BSECompany Update3d ago · 11 Nov 2026, 04:17 pm

Attached

Dr. Lal PathLabs Ltd · 539524

✦ AI SummaryMgmt Change

Dr. Lal PathLabs Ltd has announced the schedule of Analyst/ Institutional Investor meeting(s) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meetings are scheduled to take place on November 16 and 17, 2026, at JM Financial India Xchange and Avendus Spark INDX, respectively.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

f939f084-fca1-4355-8550-491d531fc23a.pdf

pdf

Download →
View document text
November 11, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, Corporate Relationship Department Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (E) Dalal Street Mumbai – 400051 Mumbai- 400001 Symbol: LALPATHLAB Scrip Code: 539524 Subject: Intimation of Schedule of Analyst/ Institutional Investor Meeting(s) Dear Sir/ Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the details of proposed schedule of Analyst/ Institutional Investor meeting(s) are as follow: Date of the Name of the Analyst/ Venue of the Type of the Meeting Institutional Investor/ Event Meeting Meeting JM Financial India Xchange November 16, Group/One-on-One 2026- 17th Annual Investor Mumbai 2026 Meeting Conference November 17, Avendus Spark INDX : Annual Group/One-on-One Mumbai 2026 Investor Conference Meeting Note: 1. Date of the aforesaid meeting/ call are subject to change due to exigencies on the part of Investors/ Company. 2. No Unpublished Price Sensitive Information will be shared during the meeting. We request you to please take the same on record. Thanking You, Yours Faithfully, For Dr. Lal PathLabs Limited Vinay Gujral Company Secretary & Compliance Officer